Search - tctmd.com

Displaying 181 - 200 of 218

Sort: Relevancy | Date

Presentation BRS 2014

Is ABSORB ready for an ‘all-comers’ randomized trial? The upcoming COMPARE-ABSORB trial

Presenter: P.C. Smits

July 26, 2014

Presentation BRS 2014

Outcomes of Clinical Registries with ABSORB BVS:Simple Lesions vs_ Real-World

Presenter: Roberto Diletti

July 25, 2014

Presentation BRS 2014

Perspectives on Polymers and Scaffold Design: Evolution ofAbsorb™ BVS

Presenter: Richard J. Rapoza

July 25, 2014

Presentation BRS 2014

Demonstration of Clinical Superiority with a Bioresorbable Vascular Scaffold: The ABSORB III + IV Clinical Trial Program

Presenter: Gregg W. Stone

July 25, 2014

Presentation BRS 2014

A Preview to ABSORB II

Presenter: Patrick W. Serruys

July 25, 2014

Presentation CIT 2014

Single Center Experience with the first 381 Absorb Implantations

Presenter: Christoph K. Naber

March 20, 2014

Presentation CIT 2014

Absorb Extend: Clinical Program up date

Presenter: Alexandre Abizaid

March 20, 2014

Presentation

Detection and Treatment of Vulnerable Plaque: PROSPECT II and PROSPECT ABSORB

Presenter: Gregg W. Stone

December 02, 2013

Presentation

Absorb Bioresorbable Vascular Scaffold System - (NEW) ABCs of Bioabsorbable Polymeric Scaffolds

Presenter: Richard J. Rapoza

December 02, 2013

Presentation TCT 2013

Rationale for Bioresorbable Vascular Scaffolds as a VP Shield: The PROSPECT ABSORB Trial

Presenter: Gregg Stone

October 30, 2013

Presentation TCT 2013

Bifurcation Strategies with the Absorb BVS Everolimus-Eluting Resorbable Scaffold: A Bench Study

Presenter: JM White

October 29, 2013

Presentation TCT 2013

TCT-36. One-year Clinical Outcomes of Diabetic Patients Treated With Everolimus-Eluting Bioresorbable Vascular Scaffolds: A Pooled Analysis From the ABSORB Cohort B and the ABSO...

Presenter: Takashi Muramatsu

October 29, 2013

Presentation TCT 2013

TCT-34. The appearance of jailed side branches post-procedure, at 6, 12, 24 and 36 months following implantation of bioresorbable vascular devices – Insights from the ABSORB...

Presenter: Yoshinobu Onuma

October 29, 2013

Presentation TCT 2013

TCT-32. First Report of the Four Year Clinical Results of The ABSORB Trial Evaluating the Absorb Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Patients...

Presenter: Bernard Chevalier

October 29, 2013

Presentation TCT 2013

TCT-31. ABSORB EXTEND: An Interim Report on the 24-month Clinical Outcomes from the First 250 Patients Enrolled

Presenter: Robert Whitbourn

October 29, 2013

Presentation TCT 2013

2 Cases: Absorb in a Distal Left Main Bifurcation and a Non Left Main Bifurcation

Presenter: Antonio Colombo

October 28, 2013

Presentation TCT 2013

Is ABSORB a Workhorse DES? Real-world Perspectives I

Presenter: Antonio Colombo

October 27, 2013

Presentation TCT 2013

The ABSORB III trial: Design, Goals and Enrollment Status

Presenter: Stephen Ellis

October 27, 2013

Presentation TCT 2013

Polylactic Acid Polymers: Chemistry and Structure in ABSORB 1.0 and 1.1

Presenter: Richard Rapoza

October 27, 2013

Presentation TCT 2013

Micro-CT Observations with ABSORB: Insights into Bifurcation Technique

Presenter: John Ormiston

October 27, 2013

Advertisement

Is ABSORB ready for an ‘all-comers’ randomized trial? The upcoming COMPARE-ABSORB trial

Outcomes of Clinical Registries with ABSORB BVS:Simple Lesions vs_ Real-World

Perspectives on Polymers and Scaffold Design: Evolution ofAbsorb™ BVS

Demonstration of Clinical Superiority with a Bioresorbable Vascular Scaffold: The ABSORB III + IV Clinical Trial Program

A Preview to ABSORB II

Single Center Experience with the first 381 Absorb Implantations

Absorb Extend: Clinical Program up date

Detection and Treatment of Vulnerable Plaque: PROSPECT II and PROSPECT ABSORB

Absorb Bioresorbable Vascular Scaffold System - (NEW) ABCs of Bioabsorbable Polymeric Scaffolds

Rationale for Bioresorbable Vascular Scaffolds as a VP Shield: The PROSPECT ABSORB Trial

Bifurcation Strategies with the Absorb BVS Everolimus-Eluting Resorbable Scaffold: A Bench Study

TCT-36. One-year Clinical Outcomes of Diabetic Patients Treated With Everolimus-Eluting Bioresorbable Vascular Scaffolds: A Pooled Analysis From the ABSORB Cohort B and the ABSO...

TCT-34. The appearance of jailed side branches post-procedure, at 6, 12, 24 and 36 months following implantation of bioresorbable vascular devices – Insights from the ABSORB...

TCT-32. First Report of the Four Year Clinical Results of The ABSORB Trial Evaluating the Absorb Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Patients...

TCT-31. ABSORB EXTEND: An Interim Report on the 24-month Clinical Outcomes from the First 250 Patients Enrolled

2 Cases: Absorb in a Distal Left Main Bifurcation and a Non Left Main Bifurcation

Is ABSORB a Workhorse DES? Real-world Perspectives I

The ABSORB III trial: Design, Goals and Enrollment Status

Polylactic Acid Polymers: Chemistry and Structure in ABSORB 1.0 and 1.1

Micro-CT Observations with ABSORB: Insights into Bifurcation Technique

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content